-The Hindustan Times By his own admission, Prime Minister Narendra Modi is "happiest" showing the door to laws that are of no use. Accordingly, his government has put in motion a plan to repeal as many as 987 obsolete laws. The law ministry will bring a new bill in the winter session of Parliament to repeal 287 obsolete laws and junk about 700 Appropriation Acts that have lost...
More »SEARCH RESULT
Made in India, by small enterprises -Charan Singh
-The Hindu The Prime Minister's call for making India a manufacturing hub and creating jobs should boost small and medium enterprises as well Prime Minister Narendra Modi's ‘Make in India' campaign is creating waves both in India and abroad. Given the government's intention to boost domestic manufacturing and create new jobs, its proposal to introduce a new policy for Micro, Small and Medium Enterprises (MSMEs) deserves a closer look. While Mr. Modi's...
More »Social Media and Technology could be a Powerful Force to Create a More Equal Society by 2030
-UNDP India New Delhi: "Social media is changing the way we live and relate to each other" said noted filmmaker Shekhar Kapur. The challenge in his view, was "how to ensure those ideas are positive and for the good?" Mr. Kapur was speaking at the Social Good Summit 2014, ‘Technology for Social Good' organized by the United Nations Development Programme in India. Talking of his vision for the world in 2030,...
More »The link between sanitation and schooling -Kiran Bhatty
-The Hindu In addition to adequate provision of funds for cleaning, sanitation training and maintenance of toilets in schools, the issue of fixing accountability must also be addressed The revival of the issue of toilets in schools has brought to the fore a discussion that has for long existed among educationists, with varying positions occupying centre stage at different times. A couple of decades ago, when the deplorable state of education began...
More »A new order
-The Business Standard A ray of hope for Indian generic drug makers Gilead Sciences, the California-headquartered biotechnology company, has authorised seven India-based drug makers - Cipla, Ranbaxy, Mylan, Strides Arcolab, Hetero, Cadila Healthcare and Sequent Scientific - to manufacture and sell the generic versions of its hepatitis C medicine, Sovaldi, in 91 developing countries. Earlier in the week, Lupin, the fourth largest Indian drug maker, announced that it will develop and supply...
More »